Longevity Health Holdings, Inc. Total Liabilities
Longevity Health Holdings, Inc. total liabilities. Based on the latest financial reports, Longevity Health Holdings, Inc. (XAGE) has total liabilities worth $8.54 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See defensive interval ratio of Longevity Health Holdings, Inc. to measure how many days the company can operate on defensive assets alone.
Total Liabilities of Longevity Health Holdings, Inc. (2021–2025)
Total liabilities of Longevity Health Holdings, Inc. from 2021 to 2025. This chart illustrates how Longevity Health Holdings, Inc.'s total liabilities have evolved over time, based on quarterly financial data.
Longevity Health Holdings, Inc. Competitors by Total Liabilities
The table below lists competitors of Longevity Health Holdings, Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Ariana Resources plc
LSE:AAU
|
UK | GBX2.34 Million |
|
BEBO Health SA
PA:MLBBO
|
France | €4.42 Million |
|
Ontrak Inc
NASDAQ:OTRK
|
USA | $13.62 Million |
|
PETREL RESOURCES (PQ4.SG)
STU:PQ4
|
Germany | €1.22 Million |
|
Storage Drop Storage Technologies Ltd
TA:STRG
|
Israel | ILA3.25 Million |
|
GCL Global Holdings Ltd Warrants
NASDAQ:GCLWW
|
USA | $123.85 Million |
|
ROBUS GROUP AS EO -60
F:LH2
|
Germany | €165.85K |
|
Pebble Beach Systems Group PLC
LSE:PEB
|
UK | GBX8.87 Million |
Liability Composition Analysis (2021–2025)
This chart breaks down Longevity Health Holdings, Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of Longevity Health Holdings, Inc..
Liquidity & Leverage Metrics
Longevity Health Holdings, Inc. Total Liabilities Ratios Explained
Longevity Health Holdings, Inc. total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.15 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -1.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 5.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Longevity Health Holdings, Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Longevity Health Holdings, Inc. (2021–2025)
The table below shows the annual total liabilities of Longevity Health Holdings, Inc. from 2021 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $8.23 Million | +33.09% |
| 2024-12-31 | $6.19 Million | -84.22% |
| 2023-12-31 | $39.20 Million | -0.86% |
| 2022-12-31 | $39.54 Million | +27.00% |
| 2021-12-31 | $31.13 Million | -- |
About Longevity Health Holdings, Inc.
Longevity Health Holdings, Inc., a bio-aesthetics company, focuses on developing, manufacturing, and marketing cosmetic skincare and haircare products. The company utilizes Carmell Secretome and Elevai Exosomes to support skin and hair health. Its Carmell Secretome consists of growth factors, proteins, and peptides extracted from allogeneic human platelets; and Elevai Exosomes constains growth fa… Read more